Just The News on MSNOpinion
Mainstream media ignore FDA COVID vaccine injury whistleblower, hype questionable safety studies
"The people talking to [New York Times reporter] Christina Jewett certainly know that inherent flaw" in self-controlled case ...
In the latest update to COVID and vaccine-related discourse bubbling up at the FDA, agency officials have recently blocked ...
The FDA proposed Thursday not adding three active ingredients in weight-loss drugs to its so-called bulks list.
As the calendar turned from April to May, a big change came to the FDA. | Katherine Szarama, Ph.D., will take over as CBER ...
The FDA names Katherine Szarama, PhD, as acting director of the Center for Biologics Evaluation and Research, succeeding ...
NanoMosaic, Inc., a leader in advanced analytical technologies for cell and gene therapy development and manufacturing, today announced its strong scientific and commercial presence at the American ...
The FDA and EMA have set out updated regulatory agendas that will shape biologics manufacturing standards in coming years. The FDA’s Center for Biologics Evaluation and Research (CBER) 2026 agenda ...
The FDA is signaling change, but actual success depends on more than simply bringing in a new leader at the Center for ...
You want that new video game so badly, but you’re trying to knock your credit card balance down. Or you’re binging your favorite TV show and can’t wait to find out if a character lives, but it’s late, ...
This marks Prasad’s second departure from the FDA as CBER head. Photo by Marvin Joseph/The Washington Post via Getty Images. Vinay Prasad is once again set to depart from his role at the US Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results